AMENDMENT 1 TO THE INHALED COLLABORATION AND OPTION AGREEMENTInhaled Collaboration and Option Agreement • June 28th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus
This Amendment no. 1 to the Agreement (“Amendment”) is made effective as of the 13th day of May 2015 (“Amendment Effective Date”) by and between:
INHALED COLLABORATION AND OPTION AGREEMENTInhaled Collaboration and Option Agreement • July 13th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
EX-10.16 24 a2235907zex-10_16.htm EX-10.16Inhaled Collaboration and Option Agreement • May 5th, 2020
Confidential treatment has been requested with respect to portions of this agreement as indicated by “[***]” and such confidential portions have been deleted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
INHALED COLLABORATION AND OPTION AGREEMENTInhaled Collaboration and Option Agreement • April 4th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
Amendment No.3 to the Inhaled Collaboration and Option AgreementInhaled Collaboration and Option Agreement • June 28th, 2019 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • New York
LIQUIDIA TECHNOLOGIES, INC., a Delaware corporation, having its principal place of business at 419 Davis Dr., Suite 100, Morrisville, NC 27560 (“Liquidia”) on the one part and;
